Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA…
Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA…
GAITHERSBURG, Md., Aug. 07, 2024 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing…
Full Enrollment Achieved in Global Phase 2 Hepatitis C Virus (HCV) Study; Complete SVR12 Results Expected 4Q’24 Bemnifosbuvir and Ruzasvir…
Positive data from a 12-week Phase 2a PET imaging trial demonstrated reduced total lung collagen, improved FVC and reduced cough…
TORONTO, ONTARIO, Aug. 06, 2024 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ: AEZS) (TSX: AEZS) (“COSCIENS”…
– Agios Expects to Receive $905 Million Payment from Royalty Pharma and $200 Million Payment from Servier in Q3 2024;…
Shares of BioVie common stock began trading on split-adjusted basis on August 6, 2024CARSON CITY, Nev., Aug. 06, 2024 (GLOBE…
Company to Also Participate in 2024 Wedbush PacGrow Healthcare ConferenceRESEARCH TRIANGLE PARK, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) — Fennec…
SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused…
Company announcement no. 6 – 24 2 August 2024 NTG Nordic Transport Group acquires SCHMALZ+SCHÖN Holding GmbH NTG Germany GmbH…